Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSNuciferine is an alkaloid that has been found in N. nucifera and has diverse biological activities.1,2,3,4,5 It acts as a partial agonist at dopamine D2 receptors, as well as an inverse agonist at the serotonin receptor subtype 5-HT7, and an antagonist at the 5-HT2B and 5-HT2C receptors (EC50s = 65.07, 150, 478, and 131 nM, respectively).1 Nuciferine is also an antagonist at schistosome Sm.5-HTRL receptors (IC50 = 240 nM) and inhibits 5-HT-induced motility of larval and adult S. mansoni when used at a concentration of 10 µM.2 It activates PPARα, PPARβ/δ, and PPARγ transcriptional activity in reporter assays and inhibits IL-6 and TNF-α production induced by LPS in RAW 264.7 cells.3 It prevents ferroptotic cell death induced by the GPX4 inhibitor RSL3 in HK-2 and HEK293T cells when used at concentrations of 10, 20, and 40 µM and prevents lipid peroxidation in a mouse model of acute kidney injury.4 Dietary administration of nuciferine (15 mg/kg) reduces increases in serum triglyceride, total cholesterol, LDL, and free fatty acid levels, as well as markers of hepatic steatosis, in a mouse model of high-fat diet-induced hyperlipidemia.5
WARNING This product is not for human or veterinary use.
1. In vitro and in vivo characterization of the alkaloid nuciferine. PLoS One 11(3), e0150602 (2016).
2. Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist. Int. J. Parasitol. Drugs Drug Resist. 6(3), 364-370 (2016).
3. Nuciferine Inhibits Proinflammatory Cytokines via the PPARs in LPS-
4. Nuciferine protects against folic acid-
5. Nuciferine prevents hepatic steatosis and injury induced by a high-